posted on 2014-01-09, 00:00authored byXu Zhang, Wei Zhang, Shwu-Fan Ma, Galina Miasniakova, Adelina Sergueeva, Tatiana Ammosova, Min Xu, Sergei Nekhai, Mehdi Nourai, Michael S. Wade, Josef T. Prchal, Joe G. N. Garcia, Roberto F. Machado, Victor R. Gordeuk
In congenital Chuvash polycythemia (CP), VHLR200W homozygosity leads to elevated hypoxia inducible factor (HIF) levels at normoxia. CP is often treated by phlebotomy resulting in iron deficiency, permitting us to examine the separate and synergistic effects of iron deficiency and HIF signaling on gene expression. We compared peripheral blood mononuclear cell gene expression profiles of eight VHLR200W homozygotes with 17 wildtype individuals with normal iron status and found 812 up-regulated and 2120 down-regulated genes at false discovery rate of 0.05. Among differential genes we identified three major gene regulation modules involving induction of innate immune responses, alteration of carbohydrate and lipid metabolism, and down-regulation of cell proliferation, stress-induced apoptosis and T-cell activation. These observations suggest molecular mechanisms for previous observations in CP of lower blood sugar without increased insulin and low oncogenic potential. Studies including 16 additional VHLR200W homozygotes with low ferritin indicated that iron deficiency enhanced the induction effect of VHLR200W for 50 genes including hemoglobin synthesis loci but suppressed the effect for 107 genes enriched for HIF-2 targets. This pattern is consistent with potentiation of HIF-1α protein stability by iron deficiency but a trend for down-regulation of HIF-2α translation by iron deficiency overriding an increase in HIF-2α protein stability.
Funding
This work was supported in part by R01 HL079912-04 (VRG) from the National Heart, Lung and Blood Institute (NHLBI), 2 R25-HL03679-08 (VRG) from NHLBI and the Office of Research on Minority Health, Howard University General Clinical Research Grant No. MO1-PR10284, K23HL098454 (RFM), SC1GM082325 (SN), 2G12RR003048 (SN), 8G12MD007597 (SN), and 1P30HL107253 (VRG and SN). RFM is supported by NIH
18
R01HL111656. JTP is supported by NIH-P01CA108671 and VAH
History
Publisher Statement
NOTICE: This is the author’s version of a work that was accepted for publication in Blood Cells, Molecules and Diseases. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Blood Cells, Molecules and Diseases, 2013 DOI:10.1016/j.bcmd.2013.07.016